Technoeconomic analysis (TEA) studies are vital for formulating guidelines that drive the commercialization of electrochemical CO reduction (eCOR) technologies. In this review, we first discuss the progress in the field of eCOR processes by providing current state-of-the-art metrices (e.g., faradic efficiency, current density) based on the recent heterogeneous catalysts' discovery, electrolytes, electrolyzers configuration, and electrolysis process designs. Next, we assessed the TEA studies for a wide range of eCOR final products, different modes of eCOR systems/processes, and discussed their relative competitiveness with relevant commercial products. Finally, we discuss challenges and future directions essential for eCOR commercialization by linking suggestions from TEA studies. We believe that this review will catalyze innovation in formulating advanced eCOR strategies to meet the TEA benchmarks for the conversion of CO into valuable chemicals at the industrial scale.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11562736 | PMC |
http://dx.doi.org/10.1021/acs.estlett.4c00564 | DOI Listing |
Curr Med Chem
January 2025
Department of Pediatrics, The Second Xiangya Hospital of Central South University, Changsha, Hunan, 410011, China.
Background: Hyperuricemia (HUA) is a condition characterized by excessive uric acid production and/or inadequate uric acid excretion due to abnormal purine metabolism in the human body. Uric acid deposits resulting from HUA can lead to complications such as renal damage. Currently, drugs used to treat HUA lack specificity and often come with specific toxic side effects.
View Article and Find Full Text PDFInt J Biol Sci
January 2025
Division of Nephrology, Department of Medicine, University of Connecticut School of Medicine, Farmington, CT, USA.
Cisplatin is widely used for the treatment of solid tumors and its antitumor effects are well established. However, a known complication of cisplatin administration is acute kidney injury (AKI). In this study, we examined the role of TEA domain family member 1 (TEAD1) in the pathogenesis of cisplatin-induced AKI.
View Article and Find Full Text PDFNat Prod Res
January 2025
Teerthanker Mahaveer College of Pharmacy, Teerthanker Mahaveer University, Moradabad, UP, India.
Embelin (EMB) and Piperine (PIP) alkaloids are reported for -antidiabetic, hypolipidemic, antioxidant, and anti-cancer properties. However, simultaneous analytical methods are scarce. A stability-indicating RP-HPLC method was developed with mobile phase MeOH: 0.
View Article and Find Full Text PDFAAPS PharmSciTech
January 2025
School of Traditional Chinese Pharmacy, China Pharmaceutical University, Nanjing, 211198, China.
Albendazole serves as a broad-spectrum anthelmintic medication for treating hydatid cysts and neurocysticercosis. However, its therapeutic effectiveness is limited by poor solubility. Nanocrystals offer a promising technology to address this limitation by enhancing drug solubility.
View Article and Find Full Text PDFMed Chem
January 2025
School of Pharmacy, Changzhou University, Changzhou, 213164, China.
Catechins, the main active components of tea polyphenols, boast remarkable antioxidant activities because of their unique structures. This translates to a range of potential health benefits, including fighting antibacterial, inflammation, and even cancers. However, extracting these beneficial compounds can be tricky as they're prone to degradation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!